Brophy Family and Youth Services
Education
A collaborative response to youth disengagement in regional Victoria
Case Study: Monash Institute of Pharmaceutical Sciences (MIPS)
ProjectAdvanced Pharmaceutical Science Laboratory for Global Health Project Support
Amount$1.2 million
Date2014
ProgramPast Programs | Health
| TRUST OBJECTIVES | PROJECT OBJECTIVES |
|---|---|
| This grant was approved under previous grants policy | |
| Building capacity | Increase MIPS’ and the sector’s capacity to conduct advanced pharmaceutical research in Victoria and develop next-generation solutions to global health. |
| Extending opportunity | Provide advanced training opportunities for researchers and students from Monash and beyond. |
| Collaboration and partnership | Equipment suppliers, PerkinElmer and Shimadzu, McCall McBain Foundation, Parkville medical and science precinct partners. |
Victorian Ideas, Global Impact: a new laboratory delivering global industry-standard training and research in Victoria
A $50,000 grant by HMSTrust to MIPS in 2007 for the purchase of key analytical equipment enabled early career researcher, Dr Michelle McIntosh, to develop the globally recognised and awarded inhaled oxytocin project. This led to the establishment of the HMSTrust Laboratory, the first of its kind in Australia.
Image Michelle McIntosh at the new HMSTrust Laboratory, Parkville
Snapshot
- The new HMSTrust Laboratory represents a world-first partnership between global industry partners PerkinElmer and Shimadzu.
- A simple, inhaled dose of oxytocin, developed by Dr Michelle McIntosh and her MIPS team, could prevent 41 million cases of PPH (excessive bleeding after birth) and save 2 million lives in a decade. This project has reached the critical human clinical trial phase. The capabilities of the HMSTrust Laboratory will enable this translational research to be undertaken in Victoria.
- Directly supporting capacity building, skills growth and education development, the new facility will deliver global industry-standard training in Victoria, enabling the further development of next-generation pharmaceutical scientists.
- Access to the translational laboratory is overseen by a Management Committee represented by members of the Parkville Biomedical Precinct, chaired by Professor Bill Charman, Director of MIPS.
- The Trust’s grant has directly leveraged an additional $1.45 million in international funding to support the facilities and capabilities of the new laboratory, enabling a range of individual projects to make the giant translational leap from research project to new medicine.
- The HMSTrust Laboratory commenced operating in April 2015 and was officially launched by the Victorian Minister for Health, the Hon. Jill Hennessy MP, on 12 August 2015.
- Life Scientist magazine: From little grants big labs grow
“This platform will be open access and allow Victorian researchers to continue the development of their projects within Australia.” Professor Bill Charman, Director, MIPS.
